In vitro evidence for a role of the phosphatidylinositol-5-phosphatase SHIP2 in matrix mineralization.

被引:0
|
作者
Fradet, Anais [1 ]
Fitzgerald, Jamie [1 ]
机构
[1] Henry Ford Hosp, Ctr Bone & Joint, Detroit, MI 48202 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
SA0059
引用
收藏
页码:S128 / S128
页数:1
相关论文
共 50 条
  • [21] Therapeutic Potential of SH2 Domain-Containing Inositol-5′-Phosphatase 1 (SHIP1) and SHIP2 Inhibition in Cancer
    Fuhler, Gwenny M.
    Brooks, Robert
    Toms, Bonnie
    Iyer, Sonia
    Gengo, Elizabeth A.
    Park, Mi-Young
    Gumbleton, Matthew
    Viernes, Dennis R.
    Chisholm, John D.
    Kerr, William G.
    MOLECULAR MEDICINE, 2012, 18 (01) : 65 - 75
  • [22] APOE4-VLDL inhibits the HDL-activated phosphatidylinositol 3-kinase/Akt pathway via the phosphoinositol phosphatase SHIP2
    DeKroon, Robert
    Robinette, Jennifer B.
    Hjelmeland, Anita B.
    Wiggins, Emma
    Blackwell, Morven
    Mihovilovic, Mirta
    Fujii, Makoto
    York, John
    Hart, Janet
    Kontos, Christopher
    Rich, Jeremy
    Strittmatter, Warren J.
    CIRCULATION RESEARCH, 2006, 99 (08) : 829 - 836
  • [23] The SH2 domain containing inositol 5-phosphatase SHIP2 controls phosphatidylinositol 3,4,5-trisphosphate levels in CHO-IR cells stimulated by insulin
    Blero, D
    De Smedt, F
    Pesesse, X
    Paternotte, N
    Moreau, C
    Payrastre, B
    Erneux, C
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 282 (03) : 839 - 843
  • [24] The serpin Protein C Inhibitor (PCI) interacts with phosphoinositides (PIs) and modulates the activity of the phosphoinositide-specific phosphatase SHIP2 in vitro
    Wahlmueller, F. C.
    Sokolikova, B.
    Rieger, D.
    Geiger, M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 246 - 246
  • [25] SHIP2 plays an oncogenic role in breast cancer stem cells through JNK/vimentin activation and its phosphatase activity
    Fu, Chiung-Hui
    Lin, Ruey-Jen
    Yu, John
    Chang, Wen-Wei
    Liao, Guo-Shiou
    Chang, Wen-Ying
    Tseng, Ling-Ming
    Tsai, Yi-Fang
    Yu, Jyh-Cherng
    Yu, Alice L.
    CANCER RESEARCH, 2014, 74 (19)
  • [26] Alteration of gene expression and protein solubility of the PI 5-phosphatase SHIP2 are correlated with Alzheimer's disease pathology progression
    Ando, Kunie
    Kucukali, Fahri
    Doeraene, Emilie
    Nagaraj, Siranjeevi
    Antonelli, Eugenia Maria
    Thazin Htut, May
    Yilmaz, Zehra
    Kosa, Andreea-Claudia
    Lopez-Guitierrez, Lidia
    Quintanilla-Sanchez, Carolina
    Aydin, Emmanuel
    Ramos, Ana Raquel
    Mansour, Salwa
    Turbant, Sabrina
    Schurmans, Stephane
    Sleegers, Kristel
    Erneux, Christophe
    Brion, Jean-Pierre
    Leroy, Karelle
    ACTA NEUROPATHOLOGICA, 2024, 147 (01)
  • [27] Impact of the liver-specific expression of SHIP2 (SH2-containing inositol 5′-phosphatase 2) on insulin signaling and glucose metabolism in mice
    Fukui, K
    Wada, T
    Kagawa, S
    Nagira, K
    Ikubo, M
    Ishihara, H
    Kobayashi, M
    Sasaoka, T
    DIABETES, 2005, 54 (07) : 1958 - 1967
  • [28] Localization of mRNA for SHIP2, SH2 domain-containing inositol polyphosphate 5-phosphatase, in the brain of developing and mature rats
    Kudo, M
    Saito, S
    Owada, Y
    Suzuki, H
    Kondo, H
    MOLECULAR BRAIN RESEARCH, 2000, 75 (01): : 172 - 177
  • [29] A Novel Oncogenic Role of Inositol Phosphatase SHIP2 in ER-Negative Breast Cancer Stem Cells: Involvement of JNK/Vimentin Activation
    Fu, Chiung-Hui
    Lin, Ruey-Jen
    Yu, John
    Chang, Wen-Wei
    Liao, Guo-Shiou
    Chang, Wen-Ying
    Tseng, Ling-Ming
    Tsai, Yi-Fang
    Yu, Jyh-Cherng
    Yu, Alice L.
    STEM CELLS, 2014, 32 (08) : 2048 - 2060
  • [30] SH2-containing 5′-inositol phosphatase, SHIP2, regulates cytoskeleton organization and ligand-dependent downregulation of the epidermal growth factor receptor
    Prasad, NK
    Decker, SJ
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (13) : 13129 - 13136